Fingerprint
Dive into the research topics of 'Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with EGFR sensitive mutant non-small cell lung cancer in a Real world population'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically